Patients’ own bone-marrow stromal (stem) cells could be used to treat resistant tuberculosis (TB), according to a preliminary study by an international research team.
Conventional treatment for multi-drug resistant TB uses a combination of antibiotics which are toxic to patients. In this study, published today in The Lancet Respiratory Medicine, researchers claim using patients’ own bone-marrow stromal cells is safe and could help overcome the body’s excessive inflammatory response, repair and regenerate inflammation-induced damage to lung tissue, and lead to improved cure rates.
The World Health Organization estimates that in Eastern Europe, Asia, and South Africa 450,000 people have multi-drug resistant TB, and around half of these will fail to respond to existing treatments.
TB bacteria trigger an inflammatory response in immune cells and surrounding lung tissue that can cause immune dysfunction and tissue damage. Bone-marrow mesenchymal stromal cells (MSCs) are known to migrate to areas of lung injury and inflammation and repair damaged tissue. They also modify the body’s immune response and could boost the clearance of TB bacteria.
In this phase 1 safety study, 30 patients with multi-drug resistant or extensively-drug resistant TB aged 21–65 years old receiving standard TB antibiotic treatment were also given an infusion of around 10 million of their own stromal cells. The cells were obtained from the patient’s own bone marrow, then cultured into large numbers in the laboratory before being re-transfused into the same patient.
MSC infusion was generally safe and well tolerated. During the 6 months follow-up, no serious adverse events were recorded. The most common grade 1 or 2 adverse events were high cholesterol levels (14 of 30 patients), nausea (11 patients), and lymphopenia or diarrhoea (10 patients).
Further analyses showed 16 patients treated with MSCs were deemed cured at 18 months compared with only 5 of 30 TB patients with similar disease not treated with MSCs.
Co-author Professor Alimuddin Zumla, Professor of Infectious Diseases and International Health at UCL and a BRC-supported researcher, said: “The results of this novel and exciting study show that the current challenges and difficulties of treating multi-drug resistant TB are not insurmountable, and they bring a unique opportunity with a fresh solution to treat hundreds of thousands of people who die unnecessarily of drug-resistant TB.
The Latest on: Multi-drug resistant TB
via Google News
The Latest on: Multi-drug resistant TB
- PGIMER begins using TB machine for quicker Covid testingon May 13, 2020 at 11:40 am
The GeneXpert was launched in PGIMER in 2016 to diagnose multi-drug-resistant tuberculosis (MDR-TB) for speedy detection of TB. Dr Arunaloke Chakrabarti, head, medical microbiology, said, “The ...
- Joining forces to end TB and COVID-19on May 13, 2020 at 11:28 am
Message from Dr Tereza Kasaeva, Director, WHO Global TB Programme. The current COVID-19 crisis has been a test for countries, health systems, key stakeholders, and those delivering health services at ...
- Plants Contribute Significantly As Starting Points For Development Of Modern Drugs – Ibrahimon May 13, 2020 at 5:47 am
BY NKECHI ISAACDr Ibrahim Husseini Doko Ibrahim is the director-general of the Raw Materials Research and Development Council (RMRDC). In this interview with NKECHI ISAAC, he gives a background on the ...
- An insight into Two Wheels For Life's incredible workon May 13, 2020 at 2:56 am
CEO Andrea Coleman outlines how MotoGP™'s Official Charity are continuing with their life-saving work across Africa at this difficult time ...
- Registration Committee recommends the ban use of TB drug on cropson May 12, 2020 at 3:36 am
The Registration Committee (RC) under the Central Insecticides Board and Registration Committee (CIBRC) recommended a complete ban on the use of antibiotics streptomycin and tetracycline on crops with ...
- COVID-19 could accelerate activation of dormant tuberculosis (TB)on May 10, 2020 at 7:32 pm
The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has thrown much of the world into disarray, with over 4 million people reported infected and ...
- Mr. Charles Olalekan Mensah: Saving Lives One At A Timeon May 9, 2020 at 9:55 pm
Mr. Charles Olalekan Mensah is the Managing Director/Chief Operating Officer (MD/COO), of the Institute of Human Virology Nigeria.
- RTC bus from Vizag delivers TB medicinesin Anantapuron May 9, 2020 at 6:21 pm
While Andhra Pradesh Road Transport Corporation(APSRTC) is transporting essential goods like rice, vegetables and fruits within the State, it has also taken up the task of delivering medicines. A Carg ...
- Eswatini: Responding to COVID-19 in a country already fighting a dual HIV/TB epidemicon May 8, 2020 at 9:22 am
Among the most at-risk patients are those suffering from multidrug-resistant TB (MDR-TB). To protect them, we have started using new technology called Video Observed Therapy (VOT). This means that ...
- The COVID-19 pandemic must not divert attentionon May 2, 2020 at 12:16 pm
If resources are diverted away from child and adolescent tuberculosis (TB) programmes in order to fight COVID-19, the consequences for the ...
via Bing News